БОЗУЛІФ

Product Overview

About БОЗУЛІФ

БОЗУЛІФ is a prescription medication containing the active ingredient Bosutinib, a tyrosine kinase inhibitor used in the treatment of certain types of leukemia, specifically Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL).

Key Benefits & Uses

• Treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML)
• Treatment of acute lymphoblastic leukemia (ALL) with the Philadelphia chromosome
• Management of disease progression in patients with CML who have developed or are intolerant to prior therapy

Active Ingredient & Action

Bosutinib, the active ingredient in БОЗУЛІФ, works by selectively inhibiting the BCR-ABL tyrosine kinase, a protein responsible for the growth and survival of cancer cells in CML and ALL. By blocking this enzyme, Bosutinib helps to slow or stop the growth of cancer cells, allowing the body's immune system to attack and destroy them.

Important Notes

БОЗУЛІФ is available by prescription only and should be used under the guidance of a qualified healthcare professional. Patients should be monitored regularly for signs of adverse effects, including liver damage, diarrhea, and rash. It is essential to follow the recommended dosage and administration instructions to minimize the risk of side effects and ensure optimal treatment outcomes.